These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28419312)

  • 1. Minimally Invasive Transforaminal Lumbar Interbody Fusion: Meta-analysis of the Fusion Rates. What is the Optimal Graft Material?
    Parajón A; Alimi M; Navarro-Ramirez R; Christos P; Torres-Campa JM; Moriguchi Y; Lang G; Härtl R
    Neurosurgery; 2017 Dec; 81(6):958-971. PubMed ID: 28419312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion.
    Nandyala SV; Marquez-Lara A; Fineberg SJ; Pelton M; Singh K
    Spine (Phila Pa 1976); 2014 Feb; 39(3):185-91. PubMed ID: 24253788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis of minimally invasive transforaminal lumbar interbody fusion rates performed without posterolateral fusion.
    Bevevino AJ; Kang DG; Lehman RA; Van Blarcum GS; Wagner SC; Gwinn DE
    J Clin Neurosci; 2014 Oct; 21(10):1686-90. PubMed ID: 24913928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
    Rahman RK; Buchowski JM; Stephens B; Dorward IG; Koester LA; Bridwell KH
    Spine (Phila Pa 1976); 2013 Dec; 38(26):2264-71. PubMed ID: 24108280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and radiographic outcomes using local bone shavings as autograft in minimally invasive transforaminal lumbar interbody fusion.
    Kasliwal MK; Deutsch H
    World Neurosurg; 2012 Jul; 78(1-2):185-90. PubMed ID: 22120378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
    Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Device solutions for a challenging spine surgery: minimally invasive transforaminal lumbar interbody fusion (MIS TLIF).
    Sayari AJ; Patel DV; Yoo JS; Singh K
    Expert Rev Med Devices; 2019 Apr; 16(4):299-305. PubMed ID: 30917071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally invasive transforaminal lumbar interbody fusion with expandable versus static interbody devices: radiographic assessment of sagittal segmental and pelvic parameters.
    Hawasli AH; Khalifeh JM; Chatrath A; Yarbrough CK; Ray WZ
    Neurosurg Focus; 2017 Aug; 43(2):E10. PubMed ID: 28760032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.
    Chen NF; Smith ZA; Stiner E; Armin S; Sheikh H; Khoo LT
    J Neurosurg Spine; 2010 Jan; 12(1):40-6. PubMed ID: 20043763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
    Hofstetter CP; Hofer AS; Levi AD
    J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative and perioperative complications in minimally invasive transforaminal lumbar interbody fusion: a review of 513 patients.
    Wong AP; Smith ZA; Nixon AT; Lawton CD; Dahdaleh NS; Wong RH; Auffinger B; Lam S; Song JK; Liu JC; Koski TR; Fessler RG
    J Neurosurg Spine; 2015 May; 22(5):487-95. PubMed ID: 25700243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of lumbar spondylodeses using different bone grafting materials after transforaminal lumbar interbody fusion (TLIF).
    vonderHoeh NH; Voelker A; Heyde CE
    Eur Spine J; 2017 Nov; 26(11):2835-2842. PubMed ID: 28547573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the interbody bone graft area and fusion rate between minimally invasive and traditional open transforaminal lumbar interbody fusion: a retrospective short-term image analysis.
    Yao YC; Lin HH; Chou PH; Wang ST; Chang MC
    Eur Spine J; 2019 Sep; 28(9):2095-2102. PubMed ID: 31175483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion.
    Kaiser MG; Groff MW; Watters WC; Ghogawala Z; Mummaneni PV; Dailey AT; Choudhri TF; Eck JC; Sharan A; Wang JC; Dhall SS; Resnick DK
    J Neurosurg Spine; 2014 Jul; 21(1):106-32. PubMed ID: 24980593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, multi-institutional comparative effectiveness study of lumbar spine surgery in morbidly obese patients: does minimally invasive transforaminal lumbar interbody fusion result in superior outcomes?
    Adogwa O; Carr K; Thompson P; Hoang K; Darlington T; Perez E; Fatemi P; Gottfried O; Cheng J; Isaacs RE
    World Neurosurg; 2015 May; 83(5):860-6. PubMed ID: 25535070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
    Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
    J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral versus bilateral pedicle screw instrumentation for single-level minimally invasive transforaminal lumbar interbody fusion.
    Shen X; Zhang H; Gu X; Gu G; Zhou X; He S
    J Clin Neurosci; 2014 Sep; 21(9):1612-6. PubMed ID: 24814852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone union rate with recombinant human bone morphogenic protein-2 versus autologous iliac bone in PEEK cages for anterior lumbar interbody fusion.
    Flouzat-Lachaniette CH; Ghazanfari A; Bouthors C; Poignard A; Hernigou P; Allain J
    Int Orthop; 2014 Sep; 38(9):2001-7. PubMed ID: 24627122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.